The present invention relates to polyhydroxylated benzophenone compounds useful in the treatment of neurodegenerative, neurological, psychiatric and cognitive disorders, in particular those associated with a deficiency in hdac1 deacetylase activity.a presente invenção se refere a compostos de benzofenona poli-hidroxilada úteis no tratamento de doenças neurodegenerativas, neurológicas, psiquiátricas e cognitivas, em particular aquelas associadas a uma deficiência em atividade de hdac1 deacetilase.